RxDoctor Payments Data

Julio Garcia-Aguilar, MD

Colon & Rectal Surgery · Duarte, CANPI 1730143124

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $15,750 of the $25,415 with a category attached, or 62.0%. Intuitive Surgical accounts for 74.5% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2021 at $16,274 and has fallen 98.2% since, to $291 in 2025. Among colon & rectal surgery clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$25,415in general payments, 2019–2025

Across 16 payments — averaging $1588.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$19K
  • Medical Device Business Services, Inc.$5K
  • Regeneron$918
  • Intera Oncology, Inc$151

What the payments were for

  • Consulting fees$6,31825%
  • Speaking & faculty fees$15,75062%
  • Food & beverage$8473%
  • Education$2,50010%

General payments by program year

19
20
21
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Intuitive Surgical12$18,946
Medical Device Business Services, Inc.2$5,400
Regeneron1$918
Intera Oncology, Inc1$151

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$25,415 in reported general payments places this provider in the 90th percentile of 176 colon & rectal surgery providers in California.

See all colon & rectal surgery providers in California

Medicare billing

Part B allowed, 2024
$160,029
Medicare patients
248
Services billed
668

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Neomycin Sulfate21$67
Metronidazole25$22

Paid to pharmacies, not to this prescriber.

Other colon & rectal surgery in Duarte

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →